This invention is related to the use of polyurethane -based polymer as a drugdelivery device to deliver biologicallyactive octreotide at a constant rate for an extended period of time andmethods of manufactures thereof. The device is very bio-compatibleand biostable, and is useful as an implant in patients (humans and animals)for the delivery of octreotide to tissues ororgans.